Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...
Journal of Nuclear Medicine October 2024, jnumed.124.268191; DOI: https://doi.org/10.2967/jnumed.124.268191 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268351; DOI: https://doi.org/10.2967/jnumed.124.268351 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268363; DOI: https://doi.org/10.2967/jnumed.124.268363 metastatic castration-resistant prostate cancer prostate ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine October 2024, jnumed.124.268292; DOI: https://doi.org/10.2967/jnumed.124.268292 ...
Journal of Nuclear Medicine October 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948 ...
Journal of Nuclear Medicine October 2024, jnumed.124.268036; DOI: https://doi.org/10.2967/jnumed.124.268036 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...